Saintmed PCL
SET:SMD
Relative Value
There is not enough data to reliably calculate the relative value of SMD.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SMD Competitors Multiples
Saintmed PCL Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TH |
S
|
Saintmed PCL
SET:SMD
|
867.3m THB | 1.2 | 23.2 | 9.7 | 16 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
116.5B USD | 0.3 | 26.8 | 19 | 21.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.4B USD | 0.2 | 43.2 | 15.1 | 19.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
70.2B USD | 0.2 | 43.2 | 15.2 | 19.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.2B USD | 0.2 | 32 | 15.4 | 20 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.7B AUD | 5.8 | 65.5 | 49.4 | 49.4 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.1B USD | 0.7 | 23.6 | 11.3 | 15.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.6B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.1B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67B HKD | 0.1 | 8.8 | 1.6 | 2.1 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |